CAC
FATE icon

Cowen and Company’s Fate Therapeutics FATE Stock Holding History

Cowen and Company’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$151K – 576
2022
Q4 		$151K Buy
+15,000
New +$151K 0.02% 177